ArticleCommunications medicine2025

Clinical, pathological and molecular characteristics of patients with disease recurrence despite pathologic response to neoadjuvant ipilimumab plus nivolumab in stage III melanoma.

Judith M Versluis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.